3C-E: Difference between revisions
>Tracer m Added categories |
>David Hedlund {{Experience reports|erowid_experience_substance_label=3C-E}} |
||
(15 intermediate revisions by 9 users not shown) | |||
Line 1: | Line 1: | ||
{{SummarySheet}} | {{SummarySheet}} | ||
{{SubstanceBox/3C-E}} | {{SubstanceBox/3C-E}} | ||
'''3,5-Dimethoxy-4-ethoxyamphetamine''' (commonly known as '''3C-E''' or '''3C-Escaline''') is a synthetic [[psychoactive class::psychedelic]] compound of the [[chemical class::amphetamine]] chemical class. Although | '''3,5-Dimethoxy-4-ethoxyamphetamine''' (commonly known as '''3C-E''' or '''3C-Escaline''') is a synthetic [[psychoactive class::psychedelic]] compound of the [[chemical class::Substituted amphetamines|amphetamine]] chemical class. Although it's name suggests it may be related to the [[2C-x]] family, this is not the case. 3C-E has the structure of [[escaline]], a mescaline analogue, with an additional carbon rendering it a substituted amphetamine. | ||
3C-E was presumably first synthesized by [[Alexander Shulgin]] and published in his book [[PiHKAL]] in 1991.<ref>{{Citation | title=Erowid Online Books : “PIHKAL” - #25 3C-E | url=https://erowid.org/library/books_online/pihkal/pihkal025.shtml}}</ref> | |||
Today, 3C-E is used for [[recreational drug use|recreational]] and research purposes, and exclusively distributed as a gray area [[research chemical]] by online vendors. Very little is known about its effects besides its strong body high and weak visuals. | Today, 3C-E is used for [[recreational drug use|recreational]] and research purposes, and exclusively distributed as a gray area [[research chemical]] by online vendors. Very little is known about its effects besides its strong body high and weak visuals. | ||
Line 16: | Line 15: | ||
==Pharmacology== | ==Pharmacology== | ||
{{Further|Serotonergic psychedelic}} | {{Further|Serotonergic psychedelic}} | ||
Although its name suggests it may be related to the 2C-x family, this is not the case. 3C-E is actually the 3-Carbon analog of escaline, thus the name. | |||
Its pharmacology can provide strong interaction with 5-HT2A receptors, which could potentially help to prevent cluster headaches or give the compound the possibility to ease the psychological suffering associated with end-stage cancer. | |||
3C-E's [[psychedelic]] effects are believed to come from its efficacy at the [[Serotonin#The 5-HT system|5-HT<sub>2A</sub> receptor]] as a [[Agonist#Agonists|partial agonist]]. However, the role of these interactions and how they result in the [[psychedelic]] experience continues to remain elusive. | 3C-E's [[psychedelic]] effects are believed to come from its efficacy at the [[Serotonin#The 5-HT system|5-HT<sub>2A</sub> receptor]] as a [[Agonist#Agonists|partial agonist]]. However, the role of these interactions and how they result in the [[psychedelic]] experience continues to remain elusive. | ||
Line 82: | Line 85: | ||
|{{effects/cognitive| | |{{effects/cognitive| | ||
The cognitive effects of 3C-E are described as primarily stimulating | The cognitive effects of 3C-E are described as primarily stimulating than psychedelic. Higher dosages can lead to a more likely occurence of confusion. | ||
The total sum of these cognitive components regardless of the setting generally includes: | The total sum of these cognitive components regardless of the setting generally includes: | ||
Line 127: | Line 130: | ||
}} | }} | ||
}} | }} | ||
===Experience reports=== | ===Experience reports=== | ||
{{Experience reports|erowid_experience_substance_label=3C-E}} | |||
==Toxicity and harm potential== | ==Toxicity and harm potential== | ||
Line 149: | Line 152: | ||
{{DangerousInteractions/Psychedelics}} | {{DangerousInteractions/Psychedelics}} | ||
== | ==Legal status== | ||
{{legalStub}} | {{legalStub}} | ||
*'''United Kingdom | |||
*'''United States | *'''Germany''': 3C-E is controlled under the NpSG (New Psychoactive Substances Act) as of November 26, 2016.<ref>{{cite web|url=https://www.bgbl.de/xaver/bgbl/start.xav?startbk=Bundesanzeiger_BGBl&jumpTo=bgbl116s2615.pdf#__bgbl__%2F%2F*%5B%40attr_id%3D%27bgbl116s2615.pdf%27%5D__1576017393518|title=Gesetz zur Bekämpfung der Verbreitung neuer psychoaktiver Stoffe|publisher=Bundesanzeiger Verlag|access-date=December 11, 2019|language=de}}</ref><ref>{{cite web|url=https://www.gesetze-im-internet.de/npsg/anlage.html|title=Anlage NpSG|publisher=Bundesministerium der Justiz und für Verbraucherschutz|access-date=December 11, 2019|language=de}}</ref> Production and import with the aim to place it on the market, administration to another person and trading is punishable. Possession is illegal but not penalized.<ref>{{cite web|url=https://www.gesetze-im-internet.de/npsg/__4.html|title=§ 4 NpSG|publisher=Bundesministerium der Justiz und für Verbraucherschutz|access-date=December 11, 2019|language=de}}</ref> | ||
*'''Japan''': 3C-E is a controlled substance in Japan effective March 25th, 2015.<ref>{{Citation | title=危険ドラッグの成分16物質を新たに指定薬物に指定 | publisher=厚生労働省 [Ministry of Health, Labour and Welfare (MHLW)] | language=japanese | url=https://www.mhlw.go.jp/stf/houdou/0000078803.html | access-date=2 May 2022}}</ref> | |||
*'''Switzerland''': 3C-E can be considered a controlled substance as a defined derivative of a-methylphenethylamine under Verzeichnis E point 130. It is legal when used for scientific or industrial use.<ref>{{cite web|url=https://www.admin.ch/opc/de/classified-compilation/20101220/index.html|title=Verordnung des EDI über die Verzeichnisse der Betäubungsmittel, psychotropen Stoffe, Vorläuferstoffe und Hilfschemikalien|publisher=Bundeskanzlei [Federal Chancellery of Switzerland]|access-date=January 1, 2020|language=de}}</ref> | |||
*'''United Kingdom''': It is illegal to produce, supply, or import this drug under the Psychoactive Substance Act, which came into effect on May 26th, 2016.<ref>{{Citation | title=Psychoactive Substances Act 2016 | url=https://www.legislation.gov.uk/ukpga/2016/2/contents/enacted}}</ref> | |||
*'''United States''': 3C-E is technically not scheduled in the United States, but could be considered an analog of [[mescaline]] and may, therefore, be considered a Schedule I drug under the Federal Analogue Act. | |||
==See also== | ==See also== | ||
*[[Responsible use]] | *[[Responsible use]] | ||
*[[Psychoactive substance index]] | *[[Psychoactive substance index]] | ||
Line 162: | Line 170: | ||
==External links== | ==External links== | ||
*[https://en.wikipedia.org/wiki/3C-E 3C-E (Wikipedia)] | *[https://en.wikipedia.org/wiki/3C-E 3C-E (Wikipedia)] | ||
*[https://isomerdesign.com/PiHKAL/read.php?domain=pk&id=25 3C-E (PiHKAL / Isomer Design)] | *[https://isomerdesign.com/PiHKAL/read.php?domain=pk&id=25 3C-E (PiHKAL / Isomer Design)] | ||
Line 170: | Line 179: | ||
[[Category:Psychoactive substance]] | [[Category:Psychoactive substance]] | ||
[[Category: | [[Category:Psychedelic]] | ||
[[Category:Amphetamine]] | [[Category:Amphetamine]] | ||
[[Category: | [[Category:Research chemical]] | ||